Literature DB >> 26417552

Spontaneous Soft Tissue Haematomas- A Rare Presentation of Chronic Myeloid Leukemic (CML).

Manoj Lakhotia1, Hans Raj Pahadiya2, Gopal Raj Prajapati3, Akanksha Choudhary4, Ronak Gandhi4.   

Abstract

Spontaneous soft tissue haematomas are rarely found in haematological malignancies. Chronic myeloid leukemia (CML) is a myeloproliferative disorder which rarely present with thrombo-haemorrhagic phenomenon. It is a malignant clonal disorder of pleuripotent stem cells that results in increase in myeloid, erythroid and platelets cells in peripheral blood and marked myeloid hyperplasia in bone marrow. It is characterized by the presence of Philadelphia chromosome (Ph) with BCR - ABL 1 fusion gene. This gene is responsible for the formation of 210 KDa chimeric proteins with enhanced tyrosine kinase activity which leads to the abnormal bone marrow cell proliferation and to the clinical and morphologic manifestations of leukemia. Cutaneous and mucous membrane bleeding is common in CML whereas bleeding in deep soft tissue is rarely found because of qualitative and quantitative platelet abnormalities. Here, we report a case of CML (BCR-ABL rearrangement positive) who presented with large haematoma in the anterior as well as posterior compartment of left thigh and treated successfully with hydroxyurea and imatinib.

Entities:  

Keywords:  BCR-ABL; Haematoma; Imatinib; JAK 2; Philadelphia chromosome

Year:  2015        PMID: 26417552      PMCID: PMC4551898          DOI: 10.7860/JCDR/2015/14318.6172

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.

Authors:  J Thiele; H M Kvasnicka; A Schmitt-Graeff; M Spohr; V Diehl; R Zankovich; N Niederle; L D Leder
Journal:  Br J Haematol       Date:  2000-01       Impact factor: 6.998

2.  Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Baccarani; M Dreyling
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.

Authors:  R I Baker; A Manoharan
Journal:  Eur J Haematol       Date:  1988-03       Impact factor: 2.997

4.  Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.

Authors:  H M Kvasnicka; J Thiele; A Schmitt-Graeff; V Diehl; R Zankovich; N Niederle; L D Leder; H E Schaefer
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

5.  Chronic myeloid leukemia initially presenting with spontaneous mediastinal hematoma and hemothorax.

Authors:  Y C Kuo; H C Wang; K A Chu; J Y Lu
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2000-02

Review 6.  Platelet abnormalities in myeloproliferative disorders.

Authors:  S Holme; S Murphy
Journal:  Clin Lab Med       Date:  1990-12       Impact factor: 1.935

Review 7.  Chronic myelogenous leukemia, BCR-ABL1+.

Authors:  James W Vardiman
Journal:  Am J Clin Pathol       Date:  2009-08       Impact factor: 2.493

8.  The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases.

Authors:  D H Buss; J J Stuart; G E Lipscomb
Journal:  Am J Hematol       Date:  1985-12       Impact factor: 10.047

9.  Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.

Authors:  Juergen Thiele; Hans Michael Kvasnicka; Eva Varus; Esther Ollig; Annette Schmitt-Graeff; Peter Staib; Martin Griesshammer
Journal:  Leuk Lymphoma       Date:  2004-08

10.  Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.

Authors:  C V Vignal; D M Lourenço; M A Noguti; M de L Chauffaille; J Kerbauy
Journal:  Sao Paulo Med J       Date:  1997 Nov-Dec       Impact factor: 1.044

View more
  2 in total

Review 1.  Antiplatelet Therapy and Spontaneous Retroperitoneal Hematoma: A Case Report and Literature Review.

Authors:  Walid Ibrahim; Abdelaziz Mohamed; Muhammed Sheikh; Mohamed Shokr; Abubaker Hassan; Jarrett Wienberger; Luis C Afonso
Journal:  Am J Case Rep       Date:  2017-01-25

2.  Bleeding with negative coagulation screening test as initial presentation of chronic myelogenous leukemia managed by fresh frozen plasma: A case report.

Authors:  Yanzhi Wang; Lina Wang; Yaming Xi; Zijian Li
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.